Functional Analysis of PS1 Interacting Protein PSIP1
About the Research Project
Program
Award Type
Standard
Award Amount
$98,445
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
A2005319
Summary
Over the past decade, molecular geneticists have identified genes that are mutated in families with early-onset forms of AD. These genes encode presenilin 1 (PS1), presenilin 2 (PS2), and APP. G-secretase is a large macromolecular complex that consists of presenilin and several additional proteins. The focus of Dr. Zhang’s project is to examine the cell biology of another protein, termed PSIP1, an evolutionary conserved molecule with no known function. Dr. Zhang has confirmed the association of PSIP1 and PS1 in stable cell lines, and has developed highly specific anti-PSIP1 antibodies to examine the subcellular distribution and trafficking of this protein. Understanding of the molecular mechanism(s) by which PSIP1 modulates g-secretase processing may offer new insights into potential targets for therapeutic intervention in AD.
Related Grants
Alzheimer's Disease Research
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Alzheimer's Disease Research
Does Alzheimer’s Disease Accelerate Brain Aging?
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
MaríA Llorens-Martín, PhD
Current Organization
Spanish National Research Council
Does Alzheimer’s Disease Accelerate Brain Aging?
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
MaríA Llorens-Martín, PhD
Current Organization
Spanish National Research Council
Alzheimer's Disease Research
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University